nirmatrelvir and Leukemia--Lymphocytic--Chronic--B-Cell

nirmatrelvir has been researched along with Leukemia--Lymphocytic--Chronic--B-Cell* in 2 studies

2 other study(ies) available for nirmatrelvir and Leukemia--Lymphocytic--Chronic--B-Cell

Article	Year
Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir. Leukemia & lymphoma, 2023, Volume: 64, Issue:5 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ritonavir; SARS-CoV-2	2023
Immediate COVID-19 treatment in CLL. Blood, 2023, 05-04, Volume: 141, Issue:18 Topics: COVID-19; COVID-19 Drug Treatment; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ritonavir	2023